Further Studies of Gastric Hypersecretion in Chronic Renal Failure
- 19 January 1974
- Vol. 1 (5898), 96-98
- https://doi.org/10.1136/bmj.1.5898.96
Abstract
The effect of medical treatment has been studied in four patients with end-stage renal failure who suffered from severe spontaneous gastric hypersecretion, associated with very low levels of intraduodenal pH in two cases. Atropine decreased the overnight gastric acid output, but the residual acid secretion and duodenal content of acid remained dangerously high in one of the patients. Secretin inhibited the basal gastric secretion of acid in all cases and converted the pH of the duodenal contents to alkaline. While atropine cannot be used to control the gastric hypersecretion, secretin may prove to be valuable in the therapeutic management of the gastric hypersecretion of patients with chronic renal failure.Keywords
This publication has 19 references indexed in Scilit:
- PEPTIC ULCERATION IN CHRONIC RENAL FAILUREThe Lancet, 1973
- Effect of Cholecystokinin and Secretin on Gastric Hypersecretion in a Patient with the Zollinger-Ellison SyndromeAustralian and New Zealand Journal of Medicine, 1972
- Gastrointestinal Bleeding in the Renal Transplant PatientRadiology, 1972
- Disturbances in Fat Digestion Induced by Acidic Jejunal pH Due to Gastric Hypersecretion in ManGastroenterology, 1970
- pH of the Duodenum of Patients with and Without Duodenal Ulcers Measured with a Radiotelemetering CapsuleGastroenterology, 1969
- Quantitative Aspects of Synergism and Inhibition of Gastric Acid SecretionGastroenterology, 1968
- RESPONSE TO SECRETIN IN MAN1968
- Acidity at different sites in the proximal duodenum of normal subjects and patients with duodenal ulcer.Gut, 1966
- Profile of pH, Pressure, and Potential Difference at Gastroduodenal Junction in ManGastroenterology, 1965
- MALABSORPTION AND JEJUNAL ULCERATION DUE TO GASTRIC HYPERSECRETION WITH PANCREATIC ISLET-CELL HYPERPLASIAThe Lancet, 1959